1. surging nature of remote healthcare / telehealth.....I think it’s becoming clear that what was initially a Covid driven spike, is now expected to last beyond the pandemic and fast-track telehealth and med-tech adoption more broadly across the globe.
2. looking at the RSH milestone table, we are getting closer to some key items that could add significant amounts of market cap.
3. RAP CEO likely off-loading some of his stock (via exercised options) this morning at a large discount to market via an off-market crossing. Given all three RSH directors have bought large amount of stock in recent times, it makes it easier for investors to decide which of the telehealth leaders to purchase
